You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alpha agonist

Showing 1 - 25 of 4,680
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • Alpha-Agonist
  • α-adrenergic receptor agonist
  • (no location specified)
Nov 28, 2023

Type 2 Diabetes, Cardiovascular Diseases, Pharmacogenomic Drug Interaction Trial in Padova (Fenofibrate 145 mg, Placebo)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Fenofibrate 145 mg
  • Placebo
  • Padova, Padua, Italy
    University Hospital of Padova
Sep 13, 2022

Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

Recruiting
  • Glaucoma, Suspect
  • Aberration, Corneal Wavefront
  • Low dosage selective alpha-2 receptor agonists topical eyedrop
  • High dosage selective alpha-2 receptor agonists topical eyedrop
  • Banhā, QA, Egypt
    Ahmed Abdelshafy
Jan 2, 2023

Squint Trial in Aswan (Dexmedetomidine)

Recruiting
  • Squint
  • Aswan, Egypt
  • +1 more
Jul 26, 2022

Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • BXCL501 (180 micrograms)
  • +3 more
  • (no location specified)
Jan 24, 2023

Healthy Volunteers Trial in New York (Clonidine Pill)

Withdrawn
  • Healthy Volunteers
  • Clonidine Pill
  • New York, New York
    Weill Cornell Medicine
Jul 14, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • SY-1425 (tamibarotene)
  • +2 more
  • Hartford, Connecticut
  • +25 more
May 4, 2022

ADHD, Autism Spectrum Disorder Trial in Canada, United States (Randomization to either Amphetamine (AMP) class of stimulant

Not yet recruiting
  • ADHD
  • Autism Spectrum Disorder
  • Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication
  • Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
  • Irvine, California
  • +11 more
Jun 14, 2023

Obstructive Sleep Apnea Trial (Guanfacine, Hydrochlorothiazide)

Completed
Has Results
  • Obstructive Sleep Apnea
  • (no location specified)
Nov 10, 2020

Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)

Completed
  • Hair Diseases
  • +2 more
  • DA-OTC-002
  • Manaus, Brazil
    Hospital Oscar Nicolau
Oct 20, 2023

Impact of Mirabegron on Erectile Function in BPH Patients

Unknown status
  • Males With Benign Prostatic Hyperplasia Symptoms
  • Mirabegron 50 MG
  • Alpha Blockers
  • (no location specified)
Aug 6, 2020

Post Spinal Shivering Trial (Dexmedetomidine injection, Tramadol)

Not yet recruiting
  • Post Spinal Shivering
  • (no location specified)
Nov 14, 2022

Fertility Trial in Barcelona (150µg CFA (Elonva®) at stimulation day (SD) 1 and 100µg CFA(Elonva®) at SD 5, 150µg CFA (Elonva®)

Not yet recruiting
  • Fertility
  • 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5
  • 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
  • Barcelona, Spain
    Hospital Universitario Quiron Dexeus
Nov 10, 2023

Ephedrine, Intramuscular, Hypotension Trial in Brasília (Intramuscular ephedrine, Placebo)

Recruiting
  • Ephedrine
  • +3 more
  • Intramuscular ephedrine
  • Placebo
  • Brasília, DF, Brazil
    Hospital de Base do Distrito Federal
Aug 10, 2022

Dexmedetomidine, Propofol, Mechanical Ventilation Trial in Tanta (Dexmedetomidine, Propofol)

Recruiting
  • Dexmedetomidine
  • +4 more
  • Tanta, El-Gharbia, Egypt
    Tanta University
Oct 24, 2023

Critical Illness Trial in United Kingdom (Dexmedetomidine, Clonidine, Propofol)

Recruiting
  • Critical Illness
  • Belfast, United Kingdom
  • +43 more
Jan 19, 2023

Blood Loss Trial in Abakaliki (clonidine group)

Recruiting
  • Blood Loss
  • clonidine group
  • Abakaliki, Ebonyi, Nigeria
    AEFUTHA
May 9, 2022

Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or

Completed
  • Alcohol Withdrawal Syndrome
  • BZDP-Sparing Protocol
  • BZDP-Based Protocol
  • Stanford, California
    Stanford Hospital and Clinics
Jun 24, 2022